Drug	Gene	Type	Source
Erlotinib	ACACA	Text_Mining(increases(phosphorylation))	CTD
Erlotinib	AREG	Text_Mining(affects(response to substance))	CTD
Erlotinib	ATG5	Text_Mining(decreases(response to substance))	CTD
Erlotinib	ATG5	Text_Mining(increases(expression))	CTD
Erlotinib	ATG7	Text_Mining(increases(expression))	CTD
Erlotinib	AXL	Text_Mining(decreases(response to substance))	CTD
Erlotinib	AXL	Text_Mining(decreases(activity))	CTD
Erlotinib	AXL	Text_Mining(increases(response to substance))	CTD
Erlotinib	BCL2	Text_Mining(increases(expression))	CTD
Erlotinib	BCL2	Text_Mining(decreases(reaction))	CTD
Erlotinib	BCL2	Text_Mining(increases(response to substance))	CTD
Erlotinib	BCL2L2	Text_Mining(increases(expression))	CTD
Erlotinib	BCL2L2	Text_Mining(decreases(reaction))	CTD
Erlotinib	BCL2L2	Text_Mining(increases(response to substance))	CTD
Erlotinib	BECN1	Text_Mining(decreases(response to substance))	CTD
Erlotinib	BRCA1	Text_Mining(decreases(activity))	CTD
Erlotinib	BRCA1	Text_Mining(decreases(phosphorylation))	CTD
Erlotinib	CCND1	Text_Mining(decreases(reaction))	CTD
Erlotinib	CCND1	Text_Mining(increases(expression))	CTD
Erlotinib	CDH1	Text_Mining(decreases(glycosylation))	CTD
Erlotinib	CDH1	Text_Mining(increases(degradation))	CTD
Erlotinib	CDH1	Text_Mining(increases(reaction))	CTD
Erlotinib	CHFR	Text_Mining(affects(cotreatment))	CTD
Erlotinib	CHFR	Text_Mining(affects(response to substance))	CTD
Erlotinib	CYP3A4	Text_Mining(decreases(activity))	CTD
Erlotinib	CYP3A4	Text_Mining(increases(expression))	CTD
Erlotinib	DDIT3	Text_Mining(increases(expression))	CTD
Erlotinib	EGF	Text_Mining(decreases(reaction))	CTD
Erlotinib	EGF	Text_Mining(decreases(response to substance))	CTD
Erlotinib	EGF	Text_Mining(increases(reaction))	CTD
Erlotinib	EGF	Text_Mining(affects(binding))	CTD
Erlotinib	EGFR	Text_Mining(affects(cotreatment))	CTD
Erlotinib	EGFR	Text_Mining(increases(response to substance))	CTD
Erlotinib	EGFR	Text_Mining(affects(response to substance))	CTD
Erlotinib	EGFR	Text_Mining(decreases(response to substance))	CTD
Erlotinib	EGFR	Text_Mining(decreases(reaction))	CTD
Erlotinib	EGFR	Text_Mining(increases(activity))	CTD
Erlotinib	EGFR	Text_Mining(increases(phosphorylation))	CTD
Erlotinib	EGFR	Text_Mining(decreases(expression))	CTD
Erlotinib	EGFR	Text_Mining(decreases(glycosylation))	CTD
Erlotinib	EGFR	Text_Mining(increases(reaction))	CTD
Erlotinib	EGFR	Text_Mining(affects(binding))	CTD
Erlotinib	EGFR	Text_Mining(decreases(activity))	CTD
Erlotinib	EGFR	Text_Mining(decreases(phosphorylation))	CTD
Erlotinib	HBEGF	Text_Mining(decreases(reaction))	CTD
Erlotinib	HBEGF	Text_Mining(decreases(response to substance))	CTD
Erlotinib	JAK2	Text_Mining(decreases(phosphorylation))	CTD
Erlotinib	KCNH2	Text_Mining(affects(activity))	CTD
Erlotinib	KRAS	Text_Mining(increases(response to substance))	CTD
Erlotinib	MAPK1	Text_Mining(decreases(phosphorylation))	CTD
Erlotinib	MAPK3	Text_Mining(decreases(phosphorylation))	CTD
Erlotinib	MET	Text_Mining(affects(cotreatment))	CTD
Erlotinib	MET	Text_Mining(decreases(phosphorylation))	CTD
Erlotinib	MTOR	Text_Mining(decreases(phosphorylation))	CTD
Erlotinib	NOX4	Text_Mining(increases(expression))	CTD
Erlotinib	NOX4	Text_Mining(increases(stability))	CTD
Erlotinib	NOX4	Text_Mining(decreases(response to substance))	CTD
Erlotinib	NR1I2	Text_Mining(affects(binding))	CTD
Erlotinib	NR1I2	Text_Mining(increases(activity))	CTD
Erlotinib	PML	Text_Mining(increases(expression))	CTD
Erlotinib	PML	Text_Mining(increases(localization))	CTD
Erlotinib	PML	Text_Mining(decreases(response to substance))	CTD
Erlotinib	PTPN9	Text_Mining(decreases(expression))	CTD
Erlotinib	PTPN9	Text_Mining(decreases(response to substance))	CTD
Erlotinib	RAD50	Text_Mining(decreases(activity))	CTD
Erlotinib	RAD50	Text_Mining(decreases(expression))	CTD
Erlotinib	RAD51	Text_Mining(decreases(activity))	CTD
Erlotinib	RAD51	Text_Mining(decreases(expression))	CTD
Erlotinib	RPS6	Text_Mining(decreases(phosphorylation))	CTD
Erlotinib	RPS6KB1	Text_Mining(decreases(phosphorylation))	CTD
Erlotinib	SRC	Text_Mining(decreases(phosphorylation))	CTD
Erlotinib	STAT3	Text_Mining(increases(phosphorylation))	CTD
Erlotinib	STAT3	Text_Mining(decreases(reaction))	CTD
Erlotinib	STAT3	Text_Mining(increases(response to substance))	CTD
Erlotinib	TGFA	Text_Mining(decreases(reaction))	CTD
Erlotinib	TGFA	Text_Mining(decreases(response to substance))	CTD
Erlotinib	TGFB1	Text_Mining(decreases(reaction))	CTD
Erlotinib	TGFB1	Text_Mining(decreases(response to substance))	CTD
Erlotinib	TGFB1	Text_Mining(increases(reaction))	CTD
Erlotinib	AHR	AhR Potency (uM)=1.88336(uM)	D4 PubChem
Erlotinib	AHR	Potency-Replicate_1=2.6603(uM)	D4 PubChem
Erlotinib	AR	Potency-Replicate_1=21.1317(uM)	D4 PubChem
Erlotinib	CLK4	Potency=20.6665(uM)	D4 PubChem
Erlotinib	CLK4	Potency=20666.5(nM)	D4 ChEMBL
Erlotinib	CYP19A1	Potency-Replicate_1=18.8336(uM)	D4 PubChem
Erlotinib	CYP19A1	None=None(uM)	D4 PubChem
Erlotinib	EGFR	Potency=0.0008(uM)	D4 PubChem
Erlotinib	EGFR	Potency=0.0009(uM)	D4 PubChem
Erlotinib	EGFR	EGFR IC50=0.001(uM)	D4 PubChem
Erlotinib	EGFR	None=0.35(uM)	D4 PubChem
Erlotinib	EGFR	None=0.47(uM)	D4 PubChem
Erlotinib	EGFR	None=0.48(uM)	D4 PubChem
Erlotinib	EGFR	None=0.52(uM)	D4 PubChem
Erlotinib	EGFR	None=0.67(uM)	D4 PubChem
Erlotinib	EGFR	None=0.85(uM)	D4 PubChem
Erlotinib	EGFR	None=0.97(uM)	D4 PubChem
Erlotinib	EGFR	None=1.2(uM)	D4 PubChem
Erlotinib	EGFR	None=1.6(uM)	D4 PubChem
Erlotinib	EGFR	Inhibition=None(Unspecified)	D4 ChEMBL
Erlotinib	EGFR	Potency=0.9(nM)	D4 ChEMBL
Erlotinib	EGFR	Potency=0.8(nM)	D4 ChEMBL
Erlotinib	GAK	None=3.1(uM)	D4 PubChem
Erlotinib	JAK2	irf1 Inhibition [HEL cells] (IC50)=0.835(uM)	D4 PubChem
Erlotinib	JAK2	Activity=0.835(um)	D4 ChEMBL
Erlotinib	NFE2L2	Ratio Potency (uM)=2.37083(uM)	D4 PubChem
Erlotinib	NR3C1	Ratio Potency (uM)=20.5113(uM)	D4 PubChem
Erlotinib	SLK	None=None(uM)	D4 PubChem
Erlotinib	TDP1	Potency=13.3359(uM)	D4 PubChem
Erlotinib	YES1	Potency=0.9723(uM)	D4 PubChem